Description
Maintenance of fertility in men is dependent on a population of germline stem cells (known as spermatogonial stem cells or SSCs) within the testis that continually produce maturing germ cells for production of sperm. Male infertility is surprisingly common and disrupted formation or function of SSCs is potentially involved in a large number of these cases. Importantly, germline cells are highly sensitive to many cancer therapies including chemotherapeutic drugs and cancer patients can be at a high risk of permanent infertility. Therapy-resistant SSCs can restore sperm production in individuals but cellular pathways mediating the regenerative response of SSCs following testis damage remain poorly understood. This project aims to study and dissect cellular pathways and mechanisms regulating the SSC regenerative response using mouse models of chemotherapy-induced infertility. The project will involve SSC culture, molecular biology, biochemistry and genomics techniques. Development of therapies capable of promoting SSC regenerative capabilities may ultimately help in the reversal of infertility caused by cancer treatment.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
Stem cells, fertility, regeneration
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Molecular and Translational Sciences
Available options
PhD/Doctorate
Masters by research
Honours
Time commitment
Full-time
Part-time
Top-up scholarship funding available
No
Physical location
Clayton
Research webpage
Co-supervisors
Dr
Rheannon Blucher